Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

Advancing drug discovery and gaining competitive advantage through user experience (UX)

349 vues

Publié le

In this talk you will:
- Hear about the internal UX design capabilities of nine global research-based biopharmaceutical companies from a new investigation carried out in 2017
- Find out how your organisation can benefit from a free UX toolkit for life science R&D designed by the Pistoia Alliance “User Experience for Life Sciences” (UXLS) initiative, a feat which involved over 50 UX design experts from 20 life science and tech organisations
- Discover how UX offers a clear path to differentiating your business and reaping benefits for the discovery pipeline through specific case studies of UX in R&D

Speaker Bio:
Jennifer Cham, Lead User Experience Designer, EMBL-EBI
Jenny Cham is a proteomics scientist turned User Experience Designer, who founded the UX design capability at the European Bioinformatics Institute (EMBL-EBI) in 2009. She has over ten years’ experience of delivering digital solutions specifically for complex data-driven biomedical research. Alongside her day job, is involved in the User Experience for Life Science project coordinated by the Pistoia Alliance.

As a UX and digital design evangelist, Jenny writes articles and blogs about UX design for science. Her passion for “game-storming”-style workshops, design studios and graphic recording (aka “sketchnoting”) have all contributed to increasing stakeholder and user engagement in the design process, and build a community of UX early adopters in the pharmaceutical industry.

Publié dans : Santé & Médecine
  • Soyez le premier à commenter

  • Soyez le premier à aimer ceci

Advancing drug discovery and gaining competitive advantage through user experience (UX)

  1. 1. Source: Flickr Mark Doliner
  2. 2. Source: Realizing the Promise of Precision Medicine, Health Catalyst
  3. 3. Source: Kerry Bodine
  4. 4. Source: Apps4Kids Hackathon 2015 Source: Shutterstock
  5. 5. Source: Pat Keller Novartis NIBR
  6. 6. Source: Pat Keller Novartis NIBR
  7. 7. Source: Pat Keller Novartis NIBR
  8. 8. 0 0.0002 0.0004 0.0006 0.0008 0.001 0.0012 A B C D E F G H I RatioofUXFTEsinR&Dpertotalcompany headcount Large R&D-based biopharmaceutical companies
  9. 9. Source: uxplanet.org
  10. 10. Source: https://vimeo.com/245961937
  11. 11. Source: https://vimeo.com/245961937 Source: Wikimedia Commons
  12. 12. Source: Forrester courtesy of TandemSeven
  13. 13. Source: Forrester courtesy of TandemSeven
  14. 14. @JenniferCham www.jennycham.co.uk jennifer.cham@ebi.acuk

×